phase readout
saveNCT05689151: A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
RECRUITINGupdated 10d ago
community read0 votes
Sponsor: Pfizer. Phase: . Conditions: Atopic Dermatitis, Eczema
view source ↗
comments(0)
5-min edit window · permanent after that